The global bronchiectasis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Some pivotal factors that are driving the market growth include the high presence of bronchiectasis among the public and the improved infrastructure facilities in the healthcare and medical sector. Another key factor anticipate to drive the market growth include the constant R&D in the field of bronchiectasis drugs coupled with the rising competition among established drug makers.

Under the global bronchiectasis drugs market, the major types of drugs available include antibiotics and expectorants. Among these two, antibiotics have the greater demand and are anticipated to continue to stay ahead of the expectorant segment in the future years. An increase in the number of respiratory diseases has been driving the antibiotics demand. In addition, the low cost and easy availability of these antibiotics have led to the demand substantially as well.

Some key players operating in the market include Endo International Plc, GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in April 2014, Bayer HealthCare announced that the US Food and Drug Administration's (FDA) Office of Orphan Products Development has granted orphan drug designation for its investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis (NCFB). Such approvals for the novel forms of drugs from the FDA for the treatment of bronchiectasis are further anticipated to drive the market growth during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Endo International Plc, GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bronchiectasis Drugs Market by Segmentation

By Product 

• Antibiotics

• Expectorants

• Other Drugs

Global Bronchiectasis Drugs Market by Region